INS and type 2 diabetes mellitus: To be noted, the SGLT2 inhibitors work independently, albeit without insulin, ameliorate blood glucose control in all stages of T2DM in the absence of clinically relevant hypoglycemia, and could be combined with other antidiabetic drugs.